# Chemotherapy-Induced Nausea and Vomiting: Developing Drugs for Prevention Guidance for Industry: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chemotherapy-induced-nausea-and-vomiting-developing-drugs-for-prevention-guidance-for-industry-draft-guidance-for-industry/9b036fec-744d-4fca-a565-c799357b16a9

> FDA guidance document: Chemotherapy-Induced Nausea and Vomiting: Developing Drugs for Prevention Guidance for Industry: Draft Guidance for Industry. Issue date: May 19, 2021. Get complete insights and analysis.

---

## Details

- Title: Chemotherapy-Induced Nausea and Vomiting: Developing Drugs for Prevention Guidance for Industry: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-05-19
- Comment Close Date: 2021-07-19
- Last Changed: 2022-02-01
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0351">FDA-2021-D-0351</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment-draft-guidance-for-industry/db47ebb5-eadc-4f7b-a236-ac6b016c3ec7)
- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Postoperative Nausea and Vomiting: Developing Drugs for Prevention](https://www.globalkeysolutions.net/guidances/guidance-document/postoperative-nausea-and-vomiting-developing-drugs-for-prevention/d423e99c-8d8f-4f7a-bb91-694c270c2ba3)